27.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen03.05.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen03.05.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen01.05.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehen02.05.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies
Später ansehen24.04.24 | Vollzeit | Tübingen | CureVac Corporate Services GmbHCureVac Corporate Services GmbH, a wholly owned subsidiary of CureVac SE, combines the central functions of the CureVac business group. CureVac is a global biopharmaceutical company in the field of mRNA technology, with more than 20 years of expertise in researching, developing and optimizing
Später ansehen03.05.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHEvaluating combination therapies and co-medications for our development programs (e.g., by in-depth literature analysis or in pre-clinical studies). The Correlative Studies Lead function includes Taking responsibility for translating pre-clinical hypotheses into clinical biomarker strategies for the TCER
Später ansehen03.05.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHEvaluating combination therapies and co-medications for our development programs (e.g., by in-depth literature analysis or in pre-clinical studies). The Correlative Studies Lead function includes Taking responsibility for translating pre-clinical hypotheses into clinical biomarker strategies for the TCER
Später ansehen03.05.24 | Vollzeit | Tübingen | Immatics Biotechnologies GmbHEvaluating combination therapies and co-medications for our development programs (e.g., by in-depth literature analysis or in pre-clinical studies). The Correlative Studies Lead function includes Taking responsibility for translating pre-clinical hypotheses into clinical biomarker strategies for the TCER
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Combiner in Tübingen kostenlos abonnieren.